Blog

  • Nicholas Soames – 2015 Parliamentary Question to the Department of Health

    Nicholas Soames – 2015 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Nicholas Soames on 2015-11-09.

    To ask the Secretary of State for Health, if he will make an estimate of the number of additional hospitals that will be required to accommodate the predicted population rise over the next 25 years; and if he will make a statement.

    Ben Gummer

    NHS planning must be centred around the changing health needs of patients and the population. Because of this, the way the NHS delivers health and care in 25 years’ time may look very different from the way health and care is delivered today.

    The NHS will take advantage of science and technology to deliver healthcare in different ways, in care settings appropriate to people’s needs. This will include hospitals but also new primary and community settings and in people’s homes, where that suits patients and their families. The NHS will of course also need to change the way healthcare is delivered as people live longer lives, with longer term, more complex, multiple health issues. Many of these needs will be best met by supporting people to live healthier as well as longer lives, in their own homes and communities, rather than admitting them to a hospital. The Government has set a priority to transform out-of-hospital care in every community.

    The NHS Five Year Forward View sets out how the NHS will need to develop to deliver care in new and innovative ways. Different local health communities are being supported as part of the New Care Models Vanguard programme to develop a small number of new care delivery options and models. It is likely that the concept of distinctive health settings, such as within the hospital sector, or within community or primary care, will become less important, as healthcare is delivered in closer partnership with people and coordinated around their needs.

    Allowing successful innovations to be spread throughout the NHS is integral to the design of the healthcare delivery models the Vanguard programme is developing. This will facilitate the continual development of new NHS services, working in partnership with the people using them.

  • Nicholas Soames – 2015 Parliamentary Question to the Department of Health

    Nicholas Soames – 2015 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Nicholas Soames on 2015-11-09.

    To ask the Secretary of State for Health, how much the public purse received in reimbursement from each EEA country for healthcare provided to their citizens for each year from 1997-98 to 2014-15.

    Alistair Burt

    Regarding non-European Economic Area (EEA) countries, including those with reciprocal healthcare agreements with the United Kingdom, we can confirm that no reimbursements are made from the public purse in respect of healthcare provided to UK citizens.

    For non-EEA countries without a reciprocal agreement in place with the UK, it would be for the individual to pay for any healthcare needed and for that reason appropriate travel and medical insurance is highly advisable. Similarly, for those non-EEA countries with whom the UK does have a reciprocal healthcare agreement, no money changes hands between the parties to the agreement. The basis of these agreements is reciprocity – that is, necessary healthcare is provided in most cases free of charge to the visitor and the associated costs are absorbed by either side.

    The information requested on the amount received in reimbursement from EEA countries in only available for the country totals of cash payment for 2007-08 to 2014-15. That information is provided in attached table. We do not hold totals for amounts before 2007-08, as the information is hot held centrally.

  • Nicholas Soames – 2015 Parliamentary Question to the Department of Health

    Nicholas Soames – 2015 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Nicholas Soames on 2015-11-09.

    To ask the Secretary of State for Health, how much the public purse received in reimbursement from each non-EEA country with reciprocal healthcare agreements with the UK for health care provided to their nationals for each year from 1997-98 to 2014-15.

    Alistair Burt

    Regarding non-European Economic Area (EEA) countries, including those with reciprocal healthcare agreements with the United Kingdom, we can confirm that no reimbursements are made from the public purse in respect of healthcare provided to UK citizens.

    For non-EEA countries without a reciprocal agreement in place with the UK, it would be for the individual to pay for any healthcare needed and for that reason appropriate travel and medical insurance is highly advisable. Similarly, for those non-EEA countries with whom the UK does have a reciprocal healthcare agreement, no money changes hands between the parties to the agreement. The basis of these agreements is reciprocity – that is, necessary healthcare is provided in most cases free of charge to the visitor and the associated costs are absorbed by either side.

    The information requested on the amount received in reimbursement from EEA countries in only available for the country totals of cash payment for 2007-08 to 2014-15. That information is provided in attached table. We do not hold totals for amounts before 2007-08, as the information is hot held centrally.

  • Jim Shannon – 2015 Parliamentary Question to the Department of Health

    Jim Shannon – 2015 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Jim Shannon on 2015-11-09.

    To ask the Secretary of State for Health, what steps he is taking to promote his Department’s strategies to prevent cancer.

    Jane Ellison

    One of the independent Cancer Taskforce report’s six strategic priorities is to “spearhead a radical upgrade in prevention and public health”. NHS England is currently working with partners across the health system to determine how best to take forward the recommendations of the report.

    As part of putting in place a governance structure for delivery of the strategy, NHS England has appointed Cally Palmer as NHS National Cancer Director. She will lead the implementation of the strategy, as well as new cancer vanguards using outcomes-based commissioning to redesign care and patient experience. Ms Palmer is Chief Executive of the Royal Marsden Hospital.

    Public Health England (PHE) runs a number of successful campaigns relating to cancer prevention.

    The tobacco marketing programme runs a range of activity to highlight the health harms of smoking. This includes demonstrating the link between smoking and cancer, as well as encouraging smokers to make quit attempts and signposting them to proven NHS tools and services to help. These programmes have been shown to have a positive impact on reducing adult smoking prevalence.

    PHE’s flagship social marketing campaign, Change4Life, aims to help families and children in England to eat well, move more, and live longer. Some cancers are highlighted as a health consequence within the campaign messaging. The campaign has enjoyed considerable success and unparalleled levels of engagement. Since its launch in 2009, more than 2.7 million people have signed up to Change4Life and it now has more than 200 national partners. Its tools and resources incentivise and encourage behaviour change.

    These complement the Be Clear on Cancer campaigns (BCoC) that encourage symptom recognition and earlier general practitioner presentation. BCoC campaigns have been running since early 2011 and have covered a number of cancers nationally and regionally.

  • Jim Shannon – 2015 Parliamentary Question to the Department of Health

    Jim Shannon – 2015 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Jim Shannon on 2015-11-09.

    To ask the Secretary of State for Health, what steps NICE has taken to make the Novalung treatment available on the NHS.

    George Freeman

    The National Institute for Health and Care Excellence (NICE) has recommended in interventional procedures guidance that the use of extracorporeal membrane ventilators, like Novalung, may be considered as a treatment option for suitable patients in a number of conditions.

    NICE’s interventional procedures guidance is available on NICE’s website at: www.nice.org.uk/Guidance

  • Jim Shannon – 2015 Parliamentary Question to the Department of Health

    Jim Shannon – 2015 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Jim Shannon on 2015-11-09.

    To ask the Secretary of State for Health, what steps his Department is taking to reduce the number of still births; and what steps he is taking to improve communication between coroners and health professionals to inform such steps.

    Ben Gummer

    On 13 November 2015, the Government announced an ambitious campaign to halve the national rates of maternal deaths, stillbirths and neonatal deaths and brain injuries in babies by 2030.

    To help meet these aims trusts will receive a share of over £4 million of government investment to improve outcomes for women and babies. This includes:

    – a £2.24 million fund to help trusts buy monitoring or training equipment to improve safety;

    – a £500,000 investment in developing a new system for staff to review and learn from every stillbirth and neonatal death; and

    – over £1 million investment to roll out training packages developed in agreement with expertise from the Royal College of Midwives and the Royal College of Obstetricians and Gynaecologists, to make sure staff have the skills and confidence they need to deliver world-leading safe care.

    Stillbirths are certified by a registered medical practitioner if they are present at the stillbirth or examined the baby, or in the absence of a registered medical practitioner, by a midwife. The Coroners and Justice Act 2009 provides the legal framework for the coroners role, which is limited to investigating the cause of deaths. Stillborn babies are not legally classified as having died because they did not show signs of independent life after birth.

    Medical professionals will only refer a case to the senior Coroner if there is reason to suspect that a baby’s death may have been violent or unnatural. This includes babies who only briefly showed signs of independent life and/or where there is doubt about whether a child was born alive or was stillborn.

    One of the powers available to a coroner is the power to make a Rule 43 report. If the coroner feels that the evidence gives rise to a concern that circumstances creating a risk of other deaths will occur or continue to exist, he/she may make a Rule 43 report, which is sent to the organisation that has responsibility for the circumstances. A recipient of a Rule 43 report must send a written response within 56 days. The response must give details of any action which has been or is proposed will be taken, or provide an explanation when no action is proposed.

  • Jim Shannon – 2015 Parliamentary Question to the Department of Health

    Jim Shannon – 2015 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Jim Shannon on 2015-11-09.

    To ask the Secretary of State for Health, what estimate he has made of the cost to the NHS of treating endometriosis in the last year.

    Jane Ellison

    This information is not collected centrally.

  • Jim Shannon – 2015 Parliamentary Question to the Department of Health

    Jim Shannon – 2015 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Jim Shannon on 2015-11-09.

    To ask the Secretary of State for Health, what discussions he has had with the Royal Colleges on the availability of cancer treatments relating to genetically-edited immune cells.

    Jane Ellison

    There have been no discussions with the royal colleges on the availability of cancer treatments relating to genetically-edited immune cells.

  • Jim Shannon – 2015 Parliamentary Question to the Department of Health

    Jim Shannon – 2015 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Jim Shannon on 2015-11-09.

    To ask the Secretary of State for Health, if he will make it his policy to introduce a standard dementia test for all people aged between 65 and 70.

    Jane Ellison

    Improving the treatment and care of people with dementia, reducing the incidence of dementia and improving dementia research, is a key priority for the Government. That is why in February 2015, the Prime Minister launched his Challenge on Dementia 2020 as a successor to the Prime Minister’s Challenge on Dementia 2012-2015.

    There are different models of diagnosis which are being utilised for all stages of the condition across all age groups. A range of different tests and diagnostic procedures are needed to diagnose dementia depending on the person and the type of dementia they may be suspected of presenting with, therefore a single standardised test would not be clinically appropriate.

    On 10 September 2014 NHS England published a new Dementia Toolkit aimed at helping general practitioners making a more timely diagnosis and what they can do in terms of vital post-diagnostic support. Decisions on specific health treatments and tests, however, are made at a local level to best meet the needs of the individual concerned.

    We will be raising awareness of dementia as a component of the NHS Health Check for all attendees aged between 65 and 74.

  • Jim Shannon – 2015 Parliamentary Question to the Department of Health

    Jim Shannon – 2015 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Jim Shannon on 2015-11-09.

    To ask the Secretary of State for Health, what steps he is taking to promote awareness in schools of the HPV vaccine.

    Jane Ellison

    A wide range of information tools are available and used to promote the awareness of human papillomavirus (HPV) immunisation in schools. These include leaflets, factsheets and question and answer sheets, vaccination record cards, information on the NHS Choices website, and further detailed clinical guidance to health professionals such as school nurses who are able to advise girls about HPV immunisation and respond to questions and concerns. In addition to nationally available material, local National Health Service staff also take steps to provide information on HPV immunisation in their areas. HPV vaccine uptake rates in England areamong highest in the world, with 86.7% of eligible 12 – 13 year olds receiving the full course of vaccine doses in 2013/14.